SCHEMBL17628544

SCHEMBL17628544

CCCC(S)CC(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27594188 0.86 TSHR (0.37)
SCHEMBL27374204 0.81
SCHEMBL26961561 0.81
SCHEMBL16466955 0.81
SCHEMBL3957110 0.78
SCHEMBL2807296 0.78
SCHEMBL9677388 0.78
SCHEMBL8219001 0.75 TDP1 (0.35)
SCHEMBL24013159 0.74
SCHEMBL385017 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108366597-A Mixture of substances 西姆莱斯有限公司 2018-08-03 CN claimed
WO-2026106950-A1 METHODS AND COMPOSITIONS FOR REDUCING MALODOR TAXA TECHNOLOGIES, INC. (US) 2026-05-21 WO disclosed
WO-2025201765-A1 COSMETIC COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2025-10-02 WO disclosed
WO-2025202590-A1 STAPHYLOCOCCAL C-S LYASE INHIBITORS APTAMER GROUP PLC (GB) 2025-10-02 WO disclosed
CN-109310604-A Use of specific compounds for modifying, reducing or eliminating off-flavours 西姆莱斯有限公司 2019-02-05 CN disclosed
CN-108366597-A Mixture of substances 西姆莱斯有限公司 2018-08-03 CN disclosed
US-9555057-B2 Compositions and methods for reducing cutaneous microbiome malodor THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2017-01-31 US disclosed
CN-106178559-A Big agglomerated particle 西姆莱斯股份公司 2016-12-07 CN disclosed
US-20160263154-A1 COMPOSITIONS AND METHODS FOR ALTERING HUMAN CUTANEOUS MICROBIOME TO INCREASE GROWTH OF STAPHYLOCOCCUS EPIDERMIDIS AND REDUCE STAPHYLOCOCCUS AUREUS PROLIFERATION THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK 2016-09-15 US disclosed
US-9370476-B2 Compositions and methods for altering human cutaneous microbiome to increase growth of Staphylococcus epidermidis and reduce Staphylococcus aureus proliferation THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2016-06-21 US disclosed
CN-103781367-B The oral formulations that comprises some sweet taste triterpenes and triterpene glucoside SYMRISE AG (DE) 2016-05-25 CN disclosed
WO-2016054091-A1 COMPOSITIONS AND METHODS FOR REDUCING CUTANEOUS MICROBIOME MALODOR THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2016-04-07 WO disclosed
WO-2016054093-A1 ALTERING HUMAN CUTANEOUS MICROBIOME TO INCREASE GROWTH OF STAPHYLOCOCCUS EPIDERMIDIS AND REDUCE STAPHYLOCOCCUS AUREUS PROLIFERATION THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK (US) 2016-04-07 WO disclosed
US-20160089395-A1 COMPOSITIONS AND METHODS FOR ALTERING HUMAN CUTANEOUS MICROBIOME TO INCREASE GROWTH OF STAPHYLOCOCCUS EPIDERMIDIS AND REDUCE STAPHYLOCOCCUS AUREUS PROLIFERATION THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK 2016-03-31 US disclosed
US-20160089315-A1 COMPOSITIONS AND METHODS FOR REDUCING CUTANEOUS MICROBIOME MALODOR THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK 2016-03-31 US disclosed
CN-103781367-A Orally consumable formulations comprising certain sweet-tasting triterpenes and triterpene glycosides SYMRISE AG 2014-05-07 CN disclosed